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Abstract 
Purpose: Intensive care unit (ICU) patients are particularly susceptible to developing pressure injuries. Epidemiologic 
data is however unavailable. We aimed to provide an international picture of the extent of pressure injuries and fac‑
tors associated with ICU‑acquired pressure injuries in adult ICU patients.
Methods: International 1‑day point‑prevalence study; follow‑up for outcome assessment until hospital discharge 
(maximum 12 weeks). Factors associated with ICU‑acquired pressure injury and hospital mortality were assessed by 
generalised linear mixed‑effects regression analysis.
Results: Data from 13,254 patients in 1117 ICUs (90 countries) revealed 6747 pressure injuries; 3997 (59.2%) were ICU‑
acquired. Overall prevalence was 26.6% (95% confidence interval [CI] 25.9–27.3). ICU‑acquired prevalence was 16.2% (95% CI 
15.6–16.8). Sacrum (37%) and heels (19.5%) were most affected. Factors independently associated with ICU‑acquired pres‑
sure injuries were older age, male sex, being underweight, emergency surgery, higher Simplified Acute Physiology Score II, 
Braden score < 19, ICU stay > 3 days, comorbidities (chronic obstructive pulmonary disease, immunodeficiency), organ sup‑
port (renal replacement, mechanical ventilation on ICU admission), and being in a low or lower‑middle income‑economy. 
Gradually increasing associations with mortality were identified for increasing severity of pressure injury: stage I (odds ratio 
[OR] 1.5; 95% CI 1.2–1.8), stage II (OR 1.6; 95% CI 1.4–1.9), and stage III or worse (OR 2.8; 95% CI 2.3–3.3).
Conclusion: Pressure injuries are common in adult ICU patients. ICU‑acquired pressure injuries are associated with 
mainly intrinsic factors and mortality. Optimal care standards, increased awareness, appropriate resource allocation, 
and further research into optimal prevention are pivotal to tackle this important patient safety threat.
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Introduction
Pressure injuries are localised lesions to the skin 
and/or underlying tissues due to pressure or pres-
sure combined with shear [1, 2]. Often occurring 
at bony prominences, they can develop anywhere 
on the body. Predisposing factors include limita-
tions in activity/mobility, deficiencies in nutrition 
and skin moisture, inadequate perfusion, and the use 
of mechanical devices that exert pressure on the skin 
[3, 4]. Frequently incorrectly considered a specific 
problem of long-term residents, they may develop as 
quickly as between the first hour and 4–6 h after sus-
tained loading [5]. An international classification cat-
egorises the injuries into stages I–IV, Unstageable, and 
Suspected Deep Tissue Injury according to the extent 
of the tissue damage (Online Resource_2) [1, 2].
Pressure injuries cause pain and disability, compro-
mise the quality of life [6], and extend the length of 
hospital stay by an average of 5–8  days per pressure 
injury [7]. By increasing the need for care resources 
they are a major economic burden for healthcare sys-
tems worldwide [8–10]. In the United States, the 
incremental hospital cost per patient of treating hos-
pital-acquired pressure injuries is estimated at about 
US$10,708 and might exceed US$26.8 billion at the 
national level [11].
Patients residing in the intensive care unit (ICU) are 
extremely prone to developing pressure injuries due to 
their inherent immobility, haemodynamic instability, 
poor tissue perfusion and oxygenation, and to a plethora 
of complexly interacting intrinsic and extrinsic risk fac-
tors [12–14]. Additionally, they are highly exposed to 
medical devices [15]. Finally, medical and technologi-
cal advances have generated a substantial ICU popula-
tion of geriatric patients and long-term residents whose 
risk of developing pressure injuries might even be higher 
[16–18].
Despite the severity of the problem and the consider-
able unfavourable impact of these lesions on patient 
outcomes, patient care, and health economics, research 
interest in pressure injuries in the ICU population has 
remained restricted.
As a result, clear insight into the global epidemiology 
of pressure injuries in ICUs is still lacking [19]. A recent 
systematic review and meta-analysis on their occurrence 
in adult ICU patients found 10 studies published between 
2002 and mid-2017 reporting cumulative incidences, 
and 12 providing prevalence data only [20]. Moreover, 
the included studies’ outcomes showed large variability. 
Cumulative incidence ranged from 3 to 39.3%, prevalence 
from 11.5 to 32.7%. These large differences cannot cur-
rently be explained due to a lack of large study cohorts 
capable of dealing with the clinical heterogeneity that 
is typical for the ICU setting, and with variations in the 
availability of healthcare resources worldwide.
The objective of this study was to provide an up-to-date 
picture of the extent and factors associated with pres-
sure injuries in a large, geographically diverse cohort of 
adult ICU patients. More specifically, we aimed to iden-
tify the overall and ICU-acquired prevalence according 
to geographic region and anatomical location; risk factors 
associated with ICU-acquired pressure injuries; and the 
association of pressure injuries with hospital mortality. 
We hypothesised that a number of the individual patient 
and ICU contextual factors will be associated with the 
development of pressure injuries in adult ICU patients.
Methods
A full description is in Online Resource_3.
Study design and subjects
The Decubitus in Intensive Care Units study (DecubI-
CUs) was a worldwide prospective, observational, 1-day 
point-prevalence study of pressure injuries among adult 
ICU patients with 12-weeks follow for survival status 
and length of hospital stay. All patients ≥ 18 years in ICU 
from 0:00 to 23:59:59  h on the study day were eligible; 
there were no exclusion criteria. DecubICUs was regis-
tered at ClinicalTrials.gov (NCT03270345).
Ethical approval
Overall, approval by established national, regional or 
local ethics committees and/or institutional review 
boards was granted.
Data collection
Data were collected on 15 May 2018. Alternative dates 
were set for Nigeria, Brazil and Libya due to delayed eth-
ics approval. Anonymous patient data were collected by 
case report form. They encompassed demographic and 
admission data, and physiological data pertaining to 
the study day, including the severity of disease assess-
ment by the Simplified Acute Physiology Score II (SAPS 
II) [21]. Pressure injury occurrence was measured by 
direct observation according to the international staging 
Take‑home message 
Pressure injuries are common in adult ICU patients and ICU‑acquired 
pressure injuries are associated with mainly intrinsic factors, and 
mortality. Increased clinical awareness, appropriate resource alloca‑
tion, and further investigations into the pathophysiology of pressure 
injuries in critical illness and optimal prevention strategies for ICU 
patients are pivotal to tackle this important patient safety threat.
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definitions [1, 2]. Pressure injury risk was assessed by the 
Braden scale that combines 6 subscales: mobility, activ-
ity, sensory perception, skin moisture, nutritional state, 
and friction/shear, with lower scores reflecting higher 
risk [22]. Follow-up data gathered were survival status, 
and length of ICU and hospital stay until hospital dis-
charge or at 12 weeks following the study day (7 August 
2018). The study protocol, including case and center 
report forms, is in Online Resource_4 and at https ://
www.esicm .org/resea rch/trial s/trial s-group -2/decub 
icus/.
To maximise uniformity in reporting, we developed a 
training module with self-test on pressure injury staging 
(Online Resource_5) [1, 2] that was validated for content 
by 3 experts and published on the study website prior to 
study initiation. Registered participants were repeatedly 
encouraged to familiarise themselves with the module 
before data collection.
Data management
Quality and integrity of the reported data were checked. 
Missing, extreme or implausible values were returned to 
the local data collectors for review. Where data remained 
questionable, the primary investigators (SOL and SIB) 
made a final adjudication about study inclusion in mutual 
agreement. Missing values mutually judged eligible for 
inclusion were imputed with median values or deduced 
from other variables reported. Remaining missings were 
omitted from the analyses.
Statistical analyses
Analyses were performed at the patient level. Overall 
pressure injury prevalence was calculated as the propor-
tion of the sample with at least one pressure injury on 
the study day, ICU-acquired prevalence as the propor-
tion with at least one pressure injury acquired in ICU on 
the study day. Prevalence is reported as numbers (n) and 
percentages with 95% confidence intervals (CI). Continu-
ous data are summarised by a median with interquartile 
range (IQR), categorical data as n (%). Univariate analyses 
used Chi square, Mann–Whitney U, and Kruskal–Wal-
lis tests, as appropriate. Survival analysis was performed 
by Kaplan–Meier procedure (log-rank test). Associa-
tions with ICU-acquired pressure injuries were examined 
by generalized linear mixed-effects regression analysis 
with logit link function and a random effect for coun-
try. All variables were included following an exploratory 
approach, irrespective of univariate analyses results. As 
analyses did not focus on a prediction but on the identi-
fication of associations, feature selection was not applied, 
particularly as the risk of overfitting was minimised given 
the limited number of covariates (n = 24 for pressure 
injury occurrence, n = 22 for hospital mortality) and the 
adequate dataset size (n = 13,254). Results are reported as 
odds ratios (OR) with 95% CIs.
Statistical analysis was performed using IBM SPSS 24.0 
(IBM Corp., NY, US) and R statistical software 3.6.1 [23].
Results
Hospitals and patients
We recruited 1117 ICUs in 90 countries (6 continents). 
Most were mixed medical-surgical units (n = 729; 65.2%) 
and in university hospitals (n = 675; 60.4%). Median 
(IQR) hospital and ICU capacities were 600 (329–1035) 
and 13 (8–20) beds, respectively; 1005 (89.9%) data col-
lectors had studied a training module on pressure injury 
staging, of which 920 (82.3%) the module developed for 
this project. Participation rates and ICU characteristics 
are in Online Resources_6 and 7, respectively.
Data from 13,254 patients were eligible for analysis. 
Their demographic characteristics are in Table  1, com-
pleteness of data in Online Resource_8.
Prevalence
We identified 6747 pressure injuries in 3526 patients, of 
which 3997 were ICU-acquired (59.2%; 2145 patients). 
Overall, 2081 patients had 1 pressure injury, 653 patients 
had 2, 411 had 3, and 381 had > 3 pressure injuries; and 
1284 patients had 1, 398 had 2, 243 had 3, and 220 had > 3 
ICU-acquired pressure injuries. Injuries were acquired 
before ICU admission in 1381 patients; developed in the 
ICU in 1922; and 233 patients developed injuries both 
before and during ICU stay.
Table  2 reports the overall and ICU-acquired preva-
lence across the 6 continents. A detailed breakdown per 
Stages and continents is in Online Resource_9. The over-
all prevalence was 26.6% (95% CI 25.9–27.3) with 18.0% 
(95% CI 17.3–18.6; n = 2383/13,254) of stage II or worse. 
Overall stage II prevalence was 11.4% (95% CI 10.9–11.9), 
stage III prevalence 4.2% (95% CI 3.9–4.6), and stage IV 
prevalence 2.0% (95% CI 1.7–2.2). Prevalence of Unstage-
able and Suspected Deep Tissue Injuries was 2.1% (95% 
CI 1.9–2.4) and 2.3% (95% CI 2.1–2.6), respectively.
ICU-acquired prevalence was 16.2% (95% CI 15.6–
16.8), with 11.0% (95% CI 10.5–11.5) of stage II or worse. 
ICU-acquired stage II prevalence was 7.5% (95% CI 7.1–
8); stage III prevalence 3.2% (95% CI 2.9–3.5), and stage 
IV prevalence 1.7% (95% CI 1.5–1.9). ICU-acquired prev-
alence of Unstageable and Suspected Deep Tissue Inju-
ries was 2% (95% CI 1.7–2.2) and 2% (95% CI 1.8–2.3), 
respectively.
ICUs from low and lower-middle-income economies, 
where the mean percentage of gross national income 
spent on healthcare is least, reported the highest overall 
prevalence of pressure injuries (40.7%, 95% CI 36.7–44.8) 
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and of ICU-acquired pressure injuries (27.7%, 95% CI 
24.1–31.5; Online Resource_10).
The sacral region and heels were the most affected ana-
tomical sites, accounting for 37 and 19.5% of all pressure 
injuries, respectively. Figure  1 shows numbers (percent-
ages) of overall and ICU-acquired pressure injuries at the 
most affected body locations. A comprehensive overview 
of all body locations according to pressure injury staging 
is in Online Resource_11.
Factors associated with ICU‑acquired pressure injuries
Generalized linear mixed-effects regression analysis 
identified the following factors as independently associ-
ated with ICU-acquired pressure injuries: older age, male 
sex, being underweight, admission due to emergency 
surgery, decreasing Braden scores, increasing ICU stay, 
chronic obstructive pulmonary disease, immunodefi-
ciency, renal replacement therapy, mechanical ventilation 
on ICU admission, higher SAPS II score, and being in a 
low or lower-middle-income economy, with strongest, 
gradually increasing associations with worsening Braden 
scores and increasing length of ICU stay before the study 
day, respectively (n = 12,533; Table 3).
Hospital mortality
Overall hospital mortality was 22.5% (95% CI 21.8–23.3; 
n = 2929/12 989). Following adjustment for demo-
graphics and morbidity data, severity of pressure injury 
showed a gradually increased association with hospi-
tal mortality: OR 1.31 (95% CI 1.1–1.55) for stage I, OR 
1.66 (95% CI 1.41–1.95) for stage II, and OR 2.31 (95% CI 
1.96–2.71) for stage III or worse, i.e. stage IV, Unstage-
able, or Suspected Deep Tissue Injury (n = 11 889; Online 
Resource_12). Figure  2 reports survival distribution for 
patients with increasing severity of pressure injuries (i.e., 
no pressure injury, stage I, stage II, and stage III or worse; 
Log-rank test: p < 0.001).
Discussion
In this point-prevalence study encompassing 1117 ICUs 
in 90 countries across 6 continents and involving 13,254 
adult patients, we found an overall pressure injury 
prevalence of 26.6% and an ICU-acquired prevalence of 
16.2%. Although the prevalence was highest in low and 
lower-middle-income economies, our findings suggest 
that pressure injuries remain a considerable burden for 
healthcare systems worldwide, and highlight the neces-
sity of additional efforts in patient safety initiatives.
These observational data confirm and reinforce pre-
vious findings resulting from meta-analysis [20]. Addi-
tionally, they are complementary to findings from 
systematic reviews aiming at determining risk factors 
for pressure injuries in ICU patients [12, 24–26]. These 
identified a broad range of factors including age, length 
of ICU stay, diabetes, mechanical ventilation, vasopres-
sor support, hypotension, and cardiovascular disease, 
and suggest that an interplay of these factors increases 
the probability of pressure injury development. Our 
data, albeit resulting from cross-sectional research and 
thereby only representing the study day, are suggestive 
for associating pressure injury in ICU with a patient 
profile characterised by high vulnerability, as evidenced 
by the following findings. First, the occurrence of pres-
sure injuries was associated with the Braden score, 
which summarises essential conditions that gradually 
contribute to a high-risk profile characterised by being 
bedridden, malnourished, incontinent, and with lim-
ited ability to react on or sense pain [22]. These condi-
tions are characteristic for a majority of ICU patients 
and mirror an overall vulnerability level. Second, older 
age was independently associated with pressure injury 
occurrence. The steadily increasing proportion of 
very old ICU residents constitutes an overt influx of 
high-risk patients given the accumulation of chronic 
comorbidities, nutritional deficiencies, immobility, and 
aging skin [17, 18]. Third, an association was found 
with organ support (mechanical ventilation and renal 
replacement therapy), which implies a high severity 
of acute illness. Finally, this high-vulnerability profile 
is completed by the finding that patients who resided 
> 12  days in ICU before the study day had a 7.5-fold 
increased risk of ICU-acquired pressure injury com-
pared to patients with a short ICU stay (≤ 3 days).
As such, our data suggest that the large majority of 
factors associated with pressure injury in ICU patients 
appear to be intrinsic or unmodifiable. This is in line with 
the unanimous agreement of experts that pressure inju-
ries can be unavoidable in haemodynamically unstable or 
critically ill/injured individuals [27]. Our findings need 
validation, preferably in longitudinal studies. Prospec-
tive high-resolution data from smaller samples might 
also identify additional modifiable factors not sought in 
this study. A hint that these may exist is the lower preva-
lence reported in Asia where increased awareness may 
have been prompted by previous large-scale initiatives on 
this topic. Until such data is generated, the variables we 
identified can at least be used to flag patients who might 
benefit from greater vigilance for pressure injuries. Also 
research into pressure injury pathophysiology and pre-
vention specifically directed towards the heterogeneous 
ICU population is recommended.
Another factor independently associated with pres-
sure injury was being in a low or middle-low income 
economy ICU. Limited availability of human and mate-
rial resources may contribute to this finding, as the mean 
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Table 1 Characteristics of included patients
Characteristic All patients 
(n = 13,254; 
100%)a
No pressure 
injuries (n = 9728; 
73.4%)a
Pressure injuries 
(n = 3526; 
26.6%)a
ICU‑acquired pressure 
injuries (n = 2145; 
16.2%)a
Age, years (M, IQR) 64 (51–74) 63 (50–74) 66 (54–75) 65 (53–74)
Sex (male) 8184 (61.8) 5923 (60.9) 2261 (64.1) 1414 (65.9)
Body Mass Index  classb
 Underweight (< 18.5) 680 (5.1) 446 (4.6) 234 (6.6) 134 (6.2)
 Normal weight (18.5–24.9) 5287 (39.9) 3944 (40.5) 1343 (38.1) 759 (35.4)
 Pre‑obesity (25–29.9) 4420 (33.3) 3259 (33.5) 1161 (32.9) 733 (34.2)
 Obesity class I (30–34.9) 1713 (12.9) 1259 (12.9) 454 (12.9) 305 (14.2)
 Obesity class II (35–40) 690 (5.2) 501 (5.2) 189 (5.4) 129 (6)
 Obesity class III (> 40) 464 (3.5) 319 (3.3) 145 (4.1) 85 (4)
Mechanical ventilation on ICU admission 7369 (55.6) 5000 (51.4) 2369 (67.2) 595 (27.8)
Type of admission
 Medical 6501 (49) 4499 (46.2) 2002 (56.8) 1114 (51.9)
 Elective surgery 29 (22.5) 2521 (25.9) 457 (13) 288 (13.4)
 Emergency surgery 2609 (19.7) 1866 (19.2) 743 (21.1) 522 (24.3)
 Trauma and burns 1066 (8.8) 842 (8.7) 324 (9.1) 221 (10.3)
Comorbidities
 Acquired Immune Deficiency Syndrome 56 (0.4) 35 (0.4) 21 (0.6) 16 (0.7)
 Chronic Obstructive Pulmonary Disease 1663 (12.5) 1058 (10.9) 605 (17.2) 368 (17.2)
 Malignancy 1509 (11.4) 1093 (11.2) 416 (11.8) 246 (11.5)
  Cancer, solid tumour 1089 (8.2) 812 (8.3) 277 (7.9) 167 (7.8)
  Metastatic cancer 378 (2.9) 280 (2.9) 98 (2.8) 47 (2.2)
  Haematologic cancer 233 (1.8) 147 (1.5) 86 (2.4) 55 (2.6)
 Immunocompromised 968 (7.3) 633 (6.5) 335 (9.5) 206 (9.6)
  Corticosteroid therapy 449 (3.4) 271 (2.8) 178 (5) 106 (4.9)
  Immunosuppression 444 (3.3) 279 (2.9) 165 (4.7) 107 (5)
  Chemotherapy 313 (2.4) 228 (2.3) 85 (2.4) 55 (2.6)
 Cirrhosis 433 (3.3) 314 (3.2) 119 (3.4) 60 (2.8)
 Diabetes 2842 (21.4) 1913 (19.7) 929 (26.3) 534 (24.9)
 Heart failure 1752 (13.2) 1132 (11.6) 620 (17.6) 373 (17.4)
 Impaired mobility 1680 (12.7) 1067 (11) 613 (17.4) 311 (14.5)
 Malnutrition 651 (4.9) 359 (3.7) 292 (8.3) 138 (6.4)
 Peripheral vascular disease 662 (5) 408 (4.2) 254 (7.2) 146 (6.8)
 Renal failure 1416 (10.7) 898 (9.2) 518 (14.7) 320 (14.9)
Simplified Acute Physiology Score II  categoryc
 ≤ 23 3473 (26.2) 2985 (30.7) 488 (13.8) 304 (14.2)
 24–33 3335 (25.2) 2616 (26.9) 719 (20.4) 431 (20.1)
 34–44 2955 (22.3) 1973 (20.3) 982 (27.9) 595 (27.7)
 ≥ 45 3491 (26.3) 2154 (22.1) 1337 (37.9) 815 (38.0)
Braden score  categoryd
 Very high risk (≤ 9) 1448 (10.9) 849 (8.8) 599 (17) 53 (2.5)
 High risk (10–12) 3928 (29.6) 2491 (25.8) 1437 (40.8) 365 (17)
 Moderate risk (13–14) 2474 (18.8) 1743 (18.1) 731 (20.8) 463 (21.6)
 Mild risk (15–18) 3689 (27.8) 3039 (31.5) 650 (18.5) 878 (41)
 No risk (19–23) 1635 (12.3) 1534 (15.9) 101 (2.9) 383 (17.9)
Length of stay in ICU prior to study day (M, IQR) 4 (1–12) 3 (1–9) 10 (4–25) 13 (5–29)
Length of stay in ICU (M, IQR) 11 (4–28) 8 (3–21) 22 (10–46) 27 (13–52)
Length of stay from ICU admission to hospital discharge (M, 
IQR)
19 (9–40) 16 (8–33) 31 (15–57) 36 (19–62)
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Results are expressed as number (percentages) if not differently indicated
ICU intensive care unit, M median, IQR interquartile range
a Totals may not sum to 13,254, 9728, 3526 and 2145, respectively, owing to missing values; an overview of the completeness of data is in Online Resource_8
b Body Mass Index is body weight in kilograms divided by body height in meters squared
c Range of possible scores is 0–163; a higher SAPS II score indicates a higher severity of disease and acute illness; scores are categorized according to the sample’s 
quartiles
d Range of possible scores is 6–23
Table 1 (continued)
Characteristic All patients 
(n = 13,254; 
100%)a
No pressure 
injuries (n = 9728; 
73.4%)a
Pressure injuries 
(n = 3526; 
26.6%)a
ICU‑acquired pressure 
injuries (n = 2145; 
16.2%)a
Length of stay in hospital after study day (M, IQR) 12 (6–27) 10 (5–23) 17 (7–35) 19 (8–36)
Patients still in ICU 3 months after study day 178 (1.3) 129 (1.3) 49 (1.4) 30 (1.4)
Patients still in non‑ICU ward 3 months after study day 781 (5.9) 531 (5.5) 250 (7.1) 171 (8)
Deceased during hospital stay 2929 (22.1) 1663 (17.1) 1266 (35.9) 812 (37.9)
28‑days mortality 1751 (13.2) 1149 (11.8) 606 (17.2) 340 (15.9)
Table 2 Overall and ICU‑acquired pressure injury prevalence according to continents
Results are expressed as number of patients (percentages) and 95% confidence interval if not differently indicated. Online Resource_9 reports more detailed 
information distributed for distinct pressure injury Stages
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Fig. 1 Anatomical locations of pressure injuries (most affected body sites). Left: Numbers (percentages) of overall pressure injuries − total number 
of pressure injuries = 6764. Right: Numbers (percentages) of intensive care unit‑acquired pressure injuries − total number of pressure injuries = 3997
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percentage of gross national income spent on healthcare 
in these economies is less than half as compared with 
high-income economies (4.9% versus 10.3%). Addition-
ally, pressure injury prevention might not be a healthcare 
priority in developing countries.
Manzano and co-workers [28] identified pressure 
injury as a significant independent predictor of mortal-
ity in mechanically ventilated patients (adjusted hazard 
ratio 1.28; 95% CI 1.003–1.65; p = 0.047). The mortal-
ity associated with pressure injuries remains however 
unclear. As their occurrence often mirrors a generally 
Table 3 Factors independently associated with ICU‑acquired pressure injury
a Economy: categorised according to the 2016 World Bank classification (https ://data.world bank.org/indic ator/SH.XPD.CHEX.GD.ZS)
Variable Odds ratio 95% confidence interval
Admission type: medical 1.15 0.94–1.4
Admission type: elective surgery 1.02 0.8–1.29
Admission type: emergency surgery 1.28 1.04–1.58
Age 1.005 1.0007–1.009
Male sex 1.21 1.08–1.36
Body Mass Index
 18.5–24.9: normal weight Reference
 < 18–5: underweight 1.58 1.23–2.01
 25–29.9: pre‑obesity 1.03 0.9–1.17
 ≥ 30: obesity 0.98 0.84–1.14
Risk of pressure injury
 Braden score 19–23: no risk Reference
 Braden score 15–18: mild risk 2.91 1.81–4.68
 Braden score 13–14: moderate risk 5.23 3.25–8.42
 Braden score 10–12: high risk 6.52 4.07–10.44
 Braden score ≤ 9: very high risk 9.72 6.01–15.71
Acquired immune deficiency syndrome 1.52 0.74–3.11
Cirrhosis 0.89 0.65–1.22
Chronic obstructive pulmonary disease 1.24 1.03–1.49
Diabetes 1.05 0.92–1.2
Heart failure 1.07 0.92–1.25
Immunocompromised 1.27 1.04–1.55
Malignancy 0.95 0.8–1.14
Peripheral vascular disease 1.19 0.95–1.51
Days in ICU before study day
 0–3 days Reference
 4–6 days in ICU before study day 2.28 1.90–2.74
 7–9 days in ICU before study day 3.57 2.91–4.37
 10–12 days in ICU before study day 4.12 3.29–5.17
 > 12 days in ICU before study day 7.51 6.42–8.78
Mechanical ventilation on admission 1.26 1.11–1.43
Sedation 0.95 0.82–1.09
Muscle relaxant use 1.08 0.83–1.41
Vasopressor use 1.04 0.91–1.2
Renal replacement 1.34 1.14–1.58
Simplified Acute Physiology Score II score 1.006 1.002–1.01
Number of patients per nurse 0.91 0.83–0.99
Economya
 High‑income economy Reference
 Upper‑middle income economy 1.09 0.65–1.85
 Low‑ + lower‑middle income economy 1.82 1–3.29
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debilitated condition and high severity of acute illness, an 
association with mortality seems reasonable. However, 
our regression analysis demonstrated a gradual increase 
in mortality with increasing severity of pressure injuries 
despite adjustment for these covariates. Even though 
this does not imply causality, this observation calls for 
clinical concern towards patients presenting with pres-
sure injuries or those at high-risk for developing such 
complications.
Stage I pressure injuries are generally considered revers-
ible if promptly identified and appropriately managed [13] 
and, therefore, often excluded from scientific reports [19]. 
They were nevertheless shown to be prone to deteriora-
tion, as in 6 Dutch acute care hospitals where 22.1% wors-
ened to a deeper lesion [29]. In line with several earlier 
prevalence reports [29], the majority of pressure injuries 
in our study were of stage I (38.1%). These currently often 
underreported injuries, however, emerged from our anal-
yses as independently associated with hospital mortality, 
which calls for considering these lesions as full quality 
indicators and for the standardized recording of this data 
in institutional and research reports.
This study has limitations. The cross-sectional design 
might have resulted in bias toward patients who have 
long ICU stays [30]. Since the length of stay is associated 
with pressure injury risk, the reported prevalence might 
not be representative for the entire ICU population. Our 
data only represents a snapshot at the study day and can-
not account for potentially influencing factors such as 
staffing levels. Data on pressure injuries on mucosal sur-
faces have not been collected as these are not staged by 
the international staging system [4]. Not all geographic 
regions are well-represented, thus impeding globally gen-
eralized results. As pressure injuries might be considered 
as a result of suboptimal care, fear of criticism or institu-
tional censure may have hampered objective reporting. If 
so, the actual prevalence might be higher than the rates 
identified. Accurate assessment of pressure injury stag-
ing is challenging and data collectors were not required 
to be qualified tissue viability experts. Despite our 
efforts to obtain consistency in reporting using a well-
documented data collection procedure and providing 
a training module, variability and errors in staging may 
have occurred. Given the scale of the study, it was how-
ever not feasible to assess the validity of the data using 
digital photographs. Nevertheless, the error resulting 
from our approach will if anything have led to random 
error in estimations, rather than a systematic error. We 
were unable to doublecheck the self-reported number of 
participants who indicated having studied the training 
module, which may be prone to social desirability bias. 
As we requested to report the number of ‘nurses’ on the 
study day, without further definition, we do not know 
whether assistant-nurses were also reported and included 
Fig. 2 Kaplan–Meier estimates of overall survival according to pressure injury status on the study day among adult intensive care unit patients. 
Green line indicates patients without pressure injuries; yellow line indicates patients whose worst pressure injury is of stage I; orange line indicates 
patients whose worst pressure injury is stage II; red line indicates patients whose worst pressure injury is stage III or worse (i.e. stage IV or Unstage‑
able or Suspected Deep Tissue Injury). Tick marks indicate censored data (hospital discharge before 12 weeks). Log‑rank test: p < 0.001
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in the calculation of the number of patients-per-nurse. 
The unexpected association of this variable with pres-
sure injury also needs further exploration. There is a 
view that Suspected Deep Tissue Injuries should not be 
included in epidemiological studies because it is unclear 
how many are actual deep tissue injuries that convert to 
pressure injuries. Their number was however small and 
unlikely to have substantial impact, if any, on the esti-
mated prevalence. Finally, our study may be prone to ran-
dom observer errors as data collectors depended on the 
reliability of patient files to determine whether a pressure 
injury was ICU-acquired.
The major strength is that it is the first to present a 
worldwide picture of the epidemiology of pressure inju-
ries in adult ICU patients and to map a high-risk profile 
based on a large global sample. It may act as an incen-
tive for tackling this patient safety issue and provide 
local and regional baseline data for quality improvement 
programmes. Furthermore, pressure injuries staging 
was assessed by the gold standard of skin inspection by 
trained outcome assessors, and the study used a rigorous 
protocol with clear attention to detail in standardising 
the data collection process.
Conclusions
This observational study identified a quarter of ICU 
patients with pressure injuries albeit with considerable 
regional variation in prevalence. However, approximately 
60% of the patients developed these lesions in ICU irre-
spective of the regional prevalence. As pressure injuries 
are a common complication and a substantial burden for 
healthcare systems worldwide, their prevention deserves 
increased clinical awareness and appropriate resource 
allocation. Besides, further investigations into the patho-
physiology of pressure injuries in critical illness and into 
optimal prevention strategies for ICU patients are pivotal 
to tackle this important patient safety threat.
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